血管成形術用氣球市場規模、佔有率和成長分析：按產品類型、材料、應用、技術、最終用戶和地區分類－2026-2033年產業預測

2024 年全球血管成形球囊市場價值為 31 億美元，預計到 2025 年將成長至 32.2 億美元，到 2033 年將成長至 44.1 億美元，在預測期（2026-2033 年）內複合年成長率為 4.0%。

血管成形術用氣球市場的主要驅動力是心血管疾病盛行率的不斷上升以及對微創治療方法日益成長的需求。此領域涵蓋多種球囊類型，包括傳統球囊、高壓球囊、刻痕球囊和藥物釋放型球囊。這些球囊在維持血管通暢性、減少永久性植入需求和縮短住院時間方面發揮著至關重要的作用。技術進步，特別是藥物釋放型球囊的進步，已證明其在解決複雜病變方面的有效性，從而加速了其在全球各個市場的臨床應用。此外，人工智慧利用先進的影像分析和基於物理的模擬，有望徹底改變器械設計，推動創新以解決複雜病變。隨著經濟指標的改善，預計健保報銷方案也將有所改進，市場對高級產品和策略合作的興趣日益濃厚，為市場擴張鋪平了道路。

全球血管成形球囊市場的成長要素

血管成形術用氣球的全球市場成長主要得益於球囊材料和輸送系統的顯著進步，這些進步提高了手術精度、病變部位的貼合度和臨床醫生的操控性。這些創新使得治療更多種類的血管疾病成為可能，增強了醫療專業人員的信心。改進的球囊設計最大限度地減少了對血管壁的損傷，並有助於在複雜的血管解剖結構中進行操作，從而擴大了其臨床應用範圍和治療適應症。隨著製造商不斷最佳化導管形狀和塗層技術，追求安全性和易用性，醫院和醫生對這些先進產品的偏好日益成長，並透過臨床實踐中更廣泛的應用進一步推動了市場成長。

全球血管成形術用氣球市場限制因素

全球血管成形術用氣球市場面臨許多限制因素，主要原因在於血管成形術手術和專用球囊器械的高成本。在醫療預算和資金資源有限的地區，這些技術的推廣應用會受到阻礙。醫院和診所通常會優先考慮其他方面的資金需求，導致他們選擇更經濟實惠的替代方案或推遲必要的升級改造，減緩了先進球囊技術的普及。此外，價格因素也會影響醫生對各種治療方案的選擇，並可能在醫保報銷不足以覆蓋器械成本的地區限制患者的就醫。這些財務挑戰疊加在一起，阻礙了市場成長並限制了技術的普及應用。

全球血管成形術球囊市場趨勢

全球血管成形球囊市場呈上升趨勢，這主要得益於藥物釋放型球囊已被證實能有效降低血管再阻塞並簡化手術流程。這項轉變促使醫療機構將這些先進器械應用於更廣泛的病變類型。醫療設備製造商正積極致力於改進藥物配方和增強給藥機制，以改善患者預後並增強臨床醫生對這些技術的信心。此外，支付方和醫院也越來越願意投資於能夠透過簡化診療路徑確保永續治療效果的解決方案，這促進了策略夥伴關係關係的形成。教育計畫也在推動高效血管內治療的過渡，同時降低治療的複雜性。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球血管成形術用氣球市場規模：依產品類型分類

• 一般氣球（常規球囊血管成形術 - POBA）
• 藥物塗層球囊（DCB）
• 切割球囊
• 球囊導管

全球血管成形術用氣球市場規模：依材料分類

• 聚合物氣球
• 尼龍
• 聚氨酯

全球血管成形術用氣球市場規模：依應用領域分類

• 冠狀動脈成形術
• 周邊血管成形術

全球血管成形術用氣球市場規模：依技術分類

• 半相容氣球
• 不合規的氣球

全球血管成形術用氣球市場規模：依最終用戶分類

• 醫院
• 門診手術中心（ASC）
• 導管檢查室

全球血管成形術用氣球市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Becton, Dickinson and Company
• Terumo Corporation
• B. Braun Melsungen AG
• Cook Medical
• Cordis Corporation
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• Teleflex Incorporated
• AngioDynamics Inc.
• Spectranetics Corporation
• Lepu Medical Technology Co., Ltd.
• Concept Medical Inc.
• Hexacath
• Natec Medical Ltd.
• Endocor GmbH
• Meril Life Sciences Pvt. Ltd.
• SIS Medical AG

結論與建議

Global Angioplasty Balloons Market size was valued at USD 3.1 Billion in 2024 and is poised to grow from USD 3.22 Billion in 2025 to USD 4.41 Billion by 2033, growing at a CAGR of 4.0% during the forecast period (2026-2033).

The angioplasty balloons market is significantly propelled by the escalating prevalence of cardiovascular diseases and the growing preference for minimally invasive treatment options. This sector features a variety of balloon types, including conventional, high pressure, scoring, and drug-coated versions, which are pivotal in maintaining vessel patency while minimizing the need for permanent implants and reducing hospital stays. Technological advancements, particularly in drug-coated balloons, have demonstrated effectiveness in addressing complex conditions, enhancing clinical adoption across various global markets. Moreover, AI is poised to revolutionize device design by utilizing advanced imaging analysis and physics-based simulations, fostering innovations that cater to intricate lesions. With favorable economic data encouraging reimbursement improvements, there is a surge of interest in premium products and strategic collaborations, paving the way for market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Angioplasty Balloons market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Angioplasty Balloons Market Segments Analysis

Global angioplasty balloons market is segmented by product type, material, application, technology, end-user and region. Based on product type, the market is segmented into Normal Balloons (Plain Old Balloon Angioplasty - POBA), Drug-Coated Balloons (DCB), Cutting Balloons and Scoring Balloons. Based on material, the market is segmented into Polymer-Based Balloons, Nylon and Polyurethane. Based on application, the market is segmented into Coronary Angioplasty and Peripheral Angioplasty. Based on technology, the market is segmented into Semi-Compliant Balloons and Non-Compliant Balloons. Based on end-user, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs) and Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Angioplasty Balloons Market

The Global Angioplasty Balloons market is propelled by significant advancements in balloon materials and delivery systems that enhance procedural accuracy, conformability to lesions, and clinician control. These innovations allow for the effective treatment of a wider variety of vascular issues, fostering greater confidence among medical professionals. Improved balloon designs minimize trauma to vessel walls and aid in navigating complex vascular anatomies, which encourages broader clinical usage and expands treatment indications. As manufacturers continue to optimize catheter profiles and coating technologies for safety and usability, the preference for these advanced products among hospitals and physicians increases, further promoting market growth through heightened clinical adoption.

Restraints in the Global Angioplasty Balloons Market

The Global Angioplasty Balloons market faces significant restraints primarily due to the high costs linked to angioplasty procedures and specialized balloon devices. In environments with restricted healthcare budgets or limited capital resources, the adoption of these technologies may be hindered. Hospitals and clinics often prioritize funding for various needs, leading to decisions that favor more affordable alternatives or postponement of necessary upgrades, thereby decelerating the acceptance of advanced balloon technologies. Additionally, price concerns can influence physicians when considering various treatment options and may restrict access in areas where reimbursement policies inadequately cover device costs. These financial challenges collectively impede market growth and limit penetration.

Market Trends of the Global Angioplasty Balloons Market

The global angioplasty balloons market is experiencing a rising trend driven by the growing adoption of drug-coated balloons, which are recognized for their efficacy in controlling restenosis and simplifying procedural workflows. This shift is prompting healthcare providers to utilize these advanced devices across a wider array of lesion types. Medical device companies are actively refining formulations and enhancing delivery mechanisms to boost patient outcomes and clinician trust in these technologies. Furthermore, an increasing willingness among payers and hospitals to invest in solutions that ensure durable results with streamlined care pathways is fostering strategic partnerships. Educational initiatives are also promoting a transition towards less complex, yet effective endovascular interventions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Angioplasty Balloons Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Normal Balloons (Plain Old Balloon Angioplasty - POBA)
• Drug-Coated Balloons (DCB)
• Cutting Balloons
• Scoring Balloons

Global Angioplasty Balloons Market Size by Material & CAGR (2026-2033)

• Market Overview
• Polymer-Based Balloons
• Nylon
• Polyurethane

Global Angioplasty Balloons Market Size by Application & CAGR (2026-2033)

• Market Overview
• Coronary Angioplasty
• Peripheral Angioplasty

Global Angioplasty Balloons Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Semi-Compliant Balloons
• Non-Compliant Balloons

Global Angioplasty Balloons Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Catheterization Laboratories

Global Angioplasty Balloons Market Size & CAGR (2026-2033)

• North America (Product Type, Material, Application, Technology, End-User)
  • US
  • Canada
• Europe (Product Type, Material, Application, Technology, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material, Application, Technology, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material, Application, Technology, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material, Application, Technology, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectranetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concept Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hexacath
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natec Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endocor GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIS Medical AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations